Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Nasmed Ozelglik Hizmetleri Ticaret AS Net Margin %?
Nasmed Ozelglik Hizmetleri Ticaret ASIST:EGEPO -2.45%73 Net Margin % is 3.33% as of Dec. 2025, which is 68% below its 10-year median of 10.27. GuruFocus rates IST:EGEPO with a GF Score™ of 73/100 and a GF Value™ of ₺8.41 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 666 Healthcare Providers & Services companies, Nasmed Ozelglik Hizmetleri Ticaret AS ranks worse than 64.11% on this metric.
IST:EGEPO'
s Net Margin % Range Over the Past 10 Years
Min: -29.35 Med: 10.27 Max: 28.75
Current: 0.22
IST:EGEPO's Net Margin % is ranked worse than 64.11% of 666
companies
in the Healthcare Providers & Services industry
Industry Median: 2.895
vs IST:EGEPO: 0.22
Nasmed Ozelglik Hizmetleri Ticaret AS (IST:EGEPO) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Nasmed Ozelglik Hizmetleri Ticaret AS Net Margin % Related Terms
Nasmed Ozelglik Hizmetleri Ticaret AS Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nasmed Ozelglik Hizmetleri Ticaret AS Net Margin % Chart
IST:EGEPO vs HCA, THC, DVA: Net Margin % Comparison
For the Medical Care Facilities subindustry, Nasmed Ozelglik Hizmetleri Ticaret AS's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nasmed Ozelglik Hizmetleri Ticaret AS Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nasmed Ozelglik Hizmetleri Ticaret AS's Net Margin % distribution charts can be found below:
* The bar in red indicates where Nasmed Ozelglik Hizmetleri Ticaret AS's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nasmed Ozelglik Hizmetleri Ticaret AS (IST:EGEPO) has a Net Margin % of 3.33% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Nasmed Ozelglik Hizmetleri Ticaret AS and its competitors. This is 68% below median its historical median of 10.27. According to the industry distribution chart, Nasmed Ozelglik Hizmetleri Ticaret AS ranks #427 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 64.1%.
Is Nasmed Ozelglik Hizmetleri Ticaret AS's Net Margin % too high?
Nasmed Ozelglik Hizmetleri Ticaret AS's current Net Margin % of 3.33% is 68% below median its 10-year median of 10.27. The Healthcare Providers & Services industry median Net Margin % is 2.90. Nasmed Ozelglik Hizmetleri Ticaret AS's value of 3.33% is 15% above this industry median. Based on the distribution chart, Nasmed Ozelglik Hizmetleri Ticaret AS ranks #427 out of 666 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Nasmed Ozelglik Hizmetleri Ticaret AS has a GF Score™ of 73/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nasmed Ozelglik Hizmetleri Ticaret AS's Net Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Nasmed Ozelglik Hizmetleri Ticaret AS ranks #427 out of 666 companies for Net Margin %. This places Nasmed Ozelglik Hizmetleri Ticaret AS in the lower half of its industry. The industry median Net Margin % is 2.90. Nasmed Ozelglik Hizmetleri Ticaret AS's value of 3.33% is 15% above this benchmark. While the company's 10-year median is 10.27 vs. the industry median of 2.90, Nasmed Ozelglik Hizmetleri Ticaret AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.90, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nasmed Ozelglik Hizmetleri Ticaret AS's current Net Margin % of 3.33% is 15% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Nasmed Ozelglik Hizmetleri Ticaret AS and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nasmed Ozelglik Hizmetleri Ticaret AS's current Net Margin % is 3.33%, which is 68% below median its own 10-year median of 10.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nasmed Ozelglik Hizmetleri Ticaret AS stock overvalued right now?
Based on GuruFocus' analysis, Nasmed Ozelglik Hizmetleri Ticaret AS (IST:EGEPO) is currently considered Significantly Overvalued. The stock's GF Value™ is ₺8.41, compared to a current price of ₺18.28 — trading 117.4% above its estimated fair value. The current Net Margin % is 3.33%, which is 68% below median its 10-year median of 10.27 and 15% above the Healthcare Providers & Services industry median of 2.90. Nasmed Ozelglik Hizmetleri Ticaret AS's overall GF Score™ is 73/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Nasmed Ozelglik Hizmetleri Ticaret AS (IST:EGEPO), the current Net Margin % is 3.33% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nasmed Ozelglik Hizmetleri Ticaret AS (IST:EGEPO) Overvalued in 2026?
Based on GuruFocus' analysis, Nasmed Ozelglik Hizmetleri Ticaret AS stock appears to be overvalued.
The current stock price of ₺18.28 is trading 117.4% above its estimated GF Value™ of ₺8.41.
GuruFocus considers Nasmed Ozelglik Hizmetleri Ticaret AS to be Significantly Overvalued.
Key valuation signals for IST:EGEPO:
Net Margin %: 3.33% (68% below median its 10-year median of 10.27)
GF Value™: ₺8.41 vs. price of ₺18.28 (117.4% above fair value)
Industry Position: 15% above the Healthcare Providers & Services median (#427 of 666)
No single metric tells the full story. See the IST:EGEPO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nasmed Ozelglik Hizmetleri Ticaret AS Business Description
Nasmed Ozel Saglik Hizmetleri Ticaret AS provides quality healthcare services. It arranges consultations, travel planning, accommodation, translation, and other relevant services for its patients 24/7.
73GF Score
Get the complete analysis for IST:EGEPO
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IST:EGEPO has been successfully added to your 
